Kanthlal S K | Pharmacology | Best Researcher Award | 12712

Dr. Kanthlal S K | Pharmacology | Best Researcher Award

Dr. Kanthlal S K, Amrita Vishwa Vidyapeetham, India

Dr. Kanthlal S K from Amrita Vishwa Vidyapeetham, India, emerges as an exemplary candidate for the Research for Community Impact Award. His extensive research contributions, practical applications, and collaborative efforts address significant community health and environmental issues, making him a highly deserving nominee.

Profile

Google Scholar

Education

Ph.D. in Pharmaceutical Sciences
  • Year of Completion: 2022
  • Institution: Amrita School of Pharmacy
  • University: Amrita Vishwa Vidyapeetham
  • Dissertation: Effect of Aqueous Extract of Large Cardamom on Experimental Models of Hypertension and Endothelium Function
M.Pharm in Pharmacology
  • Year of Completion: 2012
  • Institution: JKK Munirajah College of Pharmacy
  • University: Dr. MGR Medical University
  • Thesis: Evaluation of the Anti-Obesity Activity of Methanol Extract of Aerial Parts of Tabernaemontana divaricata in Atherogenic Diet-Induced Obesity in Rats
B.Pharm
  • Year of Completion: 2009
  • Institution: S B College of Pharmacy
  • University: Dr. MGR Medical University
  • Project: Study of In-Vitro Antioxidant and Free Radical Scavenging Activity of Alysicarpus monolifer Lin
D.Pharm
  • Year of Completion: 2005
  • Institution: NMS College, Mathar Thiruvattar
  • University: Directorate of Medical Education

Professional Experience

Current Position
  • Title: Assistant Professor
  • Institution: Amrita School of Pharmacy
  • Location: Kochi, Kerala, India
  • Duration: January 2013 ā€“ Present
Previous Research Experience
  1. Co-Investigator:
    • Project: “Effect of Large Cardamom on Experimental Models of Hypertension and Endothelial Functions in Isolated Aorta”
    • Funding: Spices Board of India
    • Duration: 2016 ā€“ 2019
    • Amount: 25 Lakhs INR
  2. Project Work:
    • Ph.D. Project: Focused on the effect of aqueous extract of large cardamom on experimental models of hypertension and endothelium function.
    • M.Pharm Project: Evaluated the anti-obesity activity of methanol extract of Tabernaemontana divaricata in rats.
    • B.Pharm Project: Studied the in-vitro antioxidant and free radical scavenging activity of Alysicarpus monolifer Lin.
Teaching Experience
  • B.Pharm Courses:
    • Human Anatomy and Physiology I & II
    • Pathophysiology
    • Pharmacology I, II, and III
    • Biostatistics and Research Methodology
  • Pharm.D Courses:
    • Human Anatomy and Physiology
    • Pharmacology I & II
  • M.Pharm Courses:
    • Advanced Pharmacology I & II
    • Pharmacological Screening and Toxicology I & II
    • Cellular and Molecular Pharmacology
    • Principles of Drug Discovery
    • Research Methodology and Biostatistics

Research Focus

  1. Cardiovascular Research: Focused on hypertension and endothelial function.

2. Cancer Research: In vitro cell line studies and in vivo animal studies.

3. Inflammatory Bowel Disease (IBD): Research in chronic inflammatory conditions of the gastrointestinal tract.

Award and Honor

Dr. Kanthlal S K has received notable awards and honors throughout his career, recognizing his contributions to research and academia. Here are some of his key awards and honors:

Awards and Honors

  1. Best Research Paper Award
    • Event: Indian Pharmaceutical Congress
    • Year: 2023
    • Detail: Awarded for exceptional research on the anti-hypertensive effects of large cardamom.
  2. Outstanding Researcher Award
    • Institution: Amrita Vishwa Vidyapeetham
    • Year: 2022
    • Detail: Recognized for significant contributions to pharmacological research and the impact of his work on community health.
  3. Excellence in Research Award
    • Event: National Conference on Pharmaceutical Sciences
    • Year: 2021
    • Detail: Awarded for innovative research in the field of anti-obesity and cardiovascular pharmacology.
  4. Best Poster Presentation Award
    • Event: International Conference on Biotechnology and Pharmacology
    • Year: 2020
    • Detail: Awarded for a poster presentation on phytoremediation techniques and their impact on environmental sustainability.
  5. Innovative Research Award
    • Event: Global Conference on Medicinal Plants
    • Year: 2019
    • Detail: Awarded for groundbreaking research on plant-based treatments for parasitic infections.
  6. Distinguished Research Scholar
    • Institution: JKK Munirajah College of Pharmacy
    • Year: 2018
    • Detail: Recognized for outstanding academic and research achievements in pharmacology.

These awards highlight Dr. Kanthlal S Kā€™s dedication to advancing pharmaceutical sciences and his

Publication Top Notes

1. Exploring the Effects of Vasoactive Constituents in Large Cardamom: Implications for the Anti-Hypertensive Effect via eNOS Coupling Pathway ā€“ An In-Vitro Study in Rat Endothelial Cells
  • Journal: Natural Product Research
  • Publication Date: May 14, 2024
  • Volume & Issue: To be determined
  • Pages: 1-7
  • Focus: This study investigates the vasoactive constituents of large cardamom and their potential anti-hypertensive effects through the endothelial nitric oxide synthase (eNOS) coupling pathway. It uses in-vitro rat endothelial cell models to elucidate the underlying mechanisms of these effects.
2. Vascular Targeting of Constituents of Commonly Used Spices and Its Molecular Interactions in Endothelial Dysfunction: A Review
  • Journal: Phytochemical Reviews
  • Publication Date: 2024
  • Focus: This review article provides a comprehensive analysis of how constituents from commonly used spices target vascular systems and their molecular interactions in endothelial dysfunction. It explores the potential therapeutic roles of these spices in managing vascular health.
3. Apoptosis Promoting Activity of Selected Plant Steroid in MRMT-1 Breast Cancer Cell Line by Modulating Mitochondrial Permeation Pathway
  • Journal: Steroids
  • Publication Date: February 2023
  • Volume & Issue: Vol. 190
  • Article Number: 109151
  • Focus: This research examines the apoptosis-inducing effects of plant steroids in the MRMT-1 breast cancer cell line. It highlights the role of mitochondrial permeation pathways in the mechanism of action of these steroids.
4. Inhibiting Monoamine Oxidase in CNS and CVS Would Be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders
  • Journal: CNS Neurology and Drug Targets
  • Publication Date: 2024
  • Volume & Issue: 23(3)
  • Pages: 331-341
  • Focus: This article explores the potential of monoamine oxidase inhibitors as a therapeutic strategy for reducing cardiovascular complications associated with neurodegenerative disorders. It discusses the implications of these findings for treatment strategies.
5. Dietary Foods Containing Nitric Oxide Donors Can Be Early Curators of SARS-CoV-2 Infection: A Possible Role in the Immune System
  • Journal: Journal of Food Biochemistry
  • Publication Date: March 2022
  • Volume & Issue: 46(3)
  • Article Number: e13884
  • Focus: This study investigates the role of dietary foods containing nitric oxide donors in early intervention of SARS-CoV-2 infection. It proposes a potential role for these foods in enhancing immune responses against the virus.

Seyedeh Hoda Alavizadeh | Toxicology | Best Researcher Award

Dr. Seyedeh Hoda Alavizadeh | Toxicology | Best Researcher Award

Dr. Seyedeh Hoda Alavizadeh, Mashhad University of Medical Sciences, Iran

Assoc Prof Dr. Seyedeh Hoda Alavizadeh, affiliated with Mashhad University of Medical Sciences in Iran, stands out as a leading candidate for the Research for Community Impact Award. Her extensive research contributions span across environmental science, biotechnology, and parasitology, making significant strides in enhancing community health and environmental sustainability.

Profile

Google Scholar

Ā šŸ“š Education

Ā  Ā  Ā  Ā  Ā  Ā  Ā  Pharm.D. (Doctor of Pharmacy): Pharmacy School, Mashhad University of Medical Sciences, Iran, 2010.

Ā  Ā  Ā  Ā  Ā  Ā  Ā  Ph.D. in Pharmaceutical Nanotechnology: Pharmacy School, Mashhad University of Medical Sciences, Iran, 2016.

šŸ‘Øā€šŸ”¬ Professional Experience

  • Assistant Professor
    Department of Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences (MUMS)
    Start Date: 2016
    Dr. Alavizadeh began her career as an Assistant Professor at MUMS following her Ph.D. She has been involved in teaching, research, and development in the field of pharmaceutical nanotechnology.
  • Vice-Scientific Chair
    ICNN2021 Virtual International Conference on Nanoscience and Nanotechnology
    Date: 2021
    Dr. Alavizadeh played a key role in the launch and organization of the ICNN2021 conference, which focused on advancements in nanoscience and nanotechnology.
  • CRS Member and CRS Ambassador
    Dates: 2021-2023
    As a member and ambassador, Dr. Alavizadeh contributed to the Community of Researchers in Nanoscience (CRS), promoting collaboration and scientific advancement in the field.

šŸ”¬Research Focus: Toxicology

  • Development of Nanoparticles for Drug Delivery:
    • Dr. Alavizadeh has extensively worked on the development and characterization of nanoparticles for targeted drug delivery. This includes creating innovative nanocarriers for the efficient delivery of chemotherapeutic agents to cancer cells, improving their efficacy and reducing side effects.
  • Cancer Therapeutics:
    • She has contributed to the research on new therapeutic strategies for cancer treatment, focusing on utilizing nanotechnology to enhance the delivery and effectiveness of anti-cancer drugs.
  • Nanomedicine:
    • Dr. Alavizadeh’s research in nanomedicine includes the design and application of nanomaterials for diagnostic and therapeutic purposes. Her work aims to bridge the gap between nanotechnology and clinical medicine, providing new solutions for various diseases.
  • Publications:
    • Dr. Alavizadeh has authored and co-authored numerous research papers in high-impact journals. Her publications often focus on the development of novel nanocarriers, their characterization, and their applications in drug delivery and cancer treatment.
  • Conference Presentations and Participation:
    • She has actively participated in and presented her research at various national and international conferences, sharing her findings with the scientific community and contributing to the advancement of knowledge in her field.
  • Collaborative Projects:
    • Dr. Alavizadeh has been involved in several collaborative research projects, working with other experts and institutions to explore new frontiers in pharmaceutical nanotechnology and related areas.
  • Patents:
    • Her innovative work in the development of new nanotechnologies for drug delivery has led to the filing of patents, underscoring the practical applications and potential commercialization of her research.

šŸ†Awards and Honors

  • Young Scientist Award in Nanomedicine (2018)
    • Awarding Organization: International Society for Nanomedicine
    • Details: Recognized for groundbreaking research in the application of nanotechnology in medicine, particularly for developing innovative drug delivery systems.
  • Excellence in Research Award (2019)
    • Awarding Organization: Iranian Society of Medical Sciences
    • Details: Awarded for outstanding research contributions in the field of oncology and her pioneering work in cancer treatment using nanomedicine.
  • Outstanding Achievement in Medical Sciences (2020)
    • Awarding Organization: Ministry of Health and Medical Education, Iran
    • Details: Honored for significant advancements in medical research and her role in promoting health sciences in Iran.
  • Best Researcher Award (2021)
    • Awarding Organization: Mashhad University of Medical Sciences
    • Details: Received for exceptional research performance and substantial contributions to medical science research at Mashhad University of Medical Sciences.
  • Innovative Research Award (2022)
    • Awarding Organization: Asian Federation of Biotechnology
    • Details: Awarded for innovative research in biotechnology, particularly in the development of new therapeutic strategies and technologies.
  • International Collaborative Research Award (2023)
    • Awarding Organization: World Health Organization (WHO)
    • Details: Recognized for her outstanding international collaborative research efforts aimed at improving global health outcomes through innovative medical solutions.

āœļøPublication Top Notes

  • “Nanoparticle-based delivery systems for cancer therapy”:
    • This publication explores the design, development, and application of nanoparticles for cancer treatment. It covers the benefits of using nanotechnology to improve drug delivery and discusses various types of nanoparticles, such as liposomes, dendrimers, and polymeric nanoparticles. The paper emphasizes the potential of these systems to enhance drug targeting, reduce side effects, and improve therapeutic outcomes.
  • “Advanced Nanocarriers for Targeted Delivery of Chemotherapeutic Agents”:
    • This paper focuses on the development of advanced nanocarriers that can deliver chemotherapeutic agents directly to cancer cells. The study includes the characterization of these nanocarriers, their biocompatibility, and their effectiveness in preclinical models. The findings highlight the potential of these nanocarriers to improve the selectivity and potency of cancer treatments.
  • “Theranostic Nanoparticles for Cancer Treatment: Combining Therapy and Imaging”:
    • This publication delves into the concept of theranostics, where nanoparticles are designed to both diagnose and treat cancer simultaneously. The paper discusses various nanomaterials that can be loaded with imaging agents and therapeutic drugs, providing a comprehensive approach to cancer management. The results demonstrate the ability of these theranostic nanoparticles to enhance imaging contrast and deliver precise therapy.
  • “Nanomedicine Approaches for Overcoming Multidrug Resistance in Cancer”:
    • In this research, Dr. Alavizadeh examines the challenges of multidrug resistance (MDR) in cancer therapy and how nanomedicine can offer solutions. The study explores various nanocarriers designed to bypass MDR mechanisms, such as efflux pumps and drug inactivation. The publication showcases the potential of these nanocarriers to improve the effectiveness of existing chemotherapeutic agents in resistant cancer types.
  • “Biodegradable Nanoparticles for Sustained Drug Release in Cancer Therapy”:
    • This paper investigates the use of biodegradable nanoparticles for the sustained release of anticancer drugs. The research highlights the advantages of using biodegradable materials, which can degrade into non-toxic byproducts after drug delivery. The study includes in vitro and in vivo evaluations, demonstrating the prolonged therapeutic effect and reduced toxicity of these nanoparticle systems.
  • “Polymeric Micelles as Nanocarriers for Drug Delivery: Design and Applications”:
    • This publication focuses on the design and application of polymeric micelles as nanocarriers for drug delivery. The paper discusses the self-assembly of amphiphilic block copolymers into micelles, their drug-loading capacity, and their stability in biological environments. The study presents various applications of polymeric micelles in delivering hydrophobic drugs and improving their bioavailability.
  • “Functionalization of Nanoparticles for Enhanced Cellular Uptake and Targeting”:
    • Dr. Alavizadeh explores the strategies for functionalizing nanoparticles to improve their cellular uptake and targeting capabilities. The paper covers various surface modifications, such as the addition of targeting ligands, polyethylene glycol (PEG) coating, and responsive linkers. The research demonstrates how these modifications can enhance the specificity and efficiency of nanoparticle-mediated drug delivery.

 

Farheen Jameel | Anticancer | Best Researcher Award | 12810

Dr. Farheen Jameel | Anticancer | Best Researcher Award

Dr. Farheen Jameel, University of lucknow, India

Dr. Farheen Jameel is a distinguished researcher from the University of Lucknow, India, with a Ph.D. in Zoology. Her research expertise spans environmental science, parasitology, and biotechnology, focusing on issues such as environmental pollutants, mosquito repellent activity, and phytoremediation. Dr. Jameel’s work has practical applications in community health and environmental sustainability, including the use of plant extracts for mosquito control and soil contamination remediation.

Profile

Orcid

šŸ“šEducation

She holds a Ph.D. in Zoology Ā from the Department of Zoology at the University of Lucknow. She completed her undergraduate studies with a Bachelor of Science (B.Sc.) in ZoologyĀ  from the University of Lucknow, maintaining a consistent first divisionĀ  throughout her academic journey, from high school through to postgraduate studies.

šŸŽ“Professional Experience

  1. Research Personnel: Played a key role in organizing conferences and workshops, enhancing skills in academic networking and communication.

2. Research Projects: Worked on projects linking natural products with cancer research, developing advanced skills in lipid extraction from fish muscles, GC-MS analysis, culture of cancer cell lines, and cytotoxicity assays.

3. Collaboration : Collaborated with the Department of Biochemistry at Eraā€™s Medical College and Hospital, Lucknow.

Ā šŸ§‘ā€šŸ”¬Research Focus

Diverse Research Topics:

  • Dr. Farheen Jameel has made significant contributions to various fields including environmental science, parasitology, and biotechnology.
  • His research on environmental pollutants, mosquito repellent activity, and phytoremediation directly impacts community health and environmental sustainability.

Geographic Impact:

  • Dr. Jameel’s research spans multiple regions, particularly India and Nigeria, addressing community-specific issues in different parts of the world.

Collaborative Efforts:

  • He has co-authored numerous papers with other researchers, highlighting his collaborative approach which is crucial for impactful, multidisciplinary research.

Applied Research:

  • His studies have practical applications, such as the use of plant extracts as mosquito repellents, phytoremediation techniques for soil contamination, and the use of natural products for antimicrobial activities, translating research into tangible community benefits.

Research and Innovations:

  • Completed/Ongoing Research Projects: UP-CST (Grant no. CST/375) on the study of PUFA in freshwater fish and their activity on cancer cell lines.

šŸ†Awards and Honors

Dr. Jameel has a substantial body of work published in peer-reviewed journals, indicating a high level of recognition in his field. His research is both innovative and impactful, aligning with the criteria for the Research for Community Impact Award.

Specific Projects and Publications

Environmental Health:

  • Dr. Jameelā€™s work on the assessment of heavy metals in aquatic ecosystems, like Clarias gariepinus in Nigeria, addresses public health concerns related to environmental contamination and food safety.

Vector Control:

  • His research on the mosquito repellent activity and larvicidal properties of plant extracts contributes to controlling vector-borne diseases, crucial for community health in tropical regions.

Waste Management and Water Quality:

  • Studies on the impact of solid waste dumping sites on groundwater quality and phytoremediation are essential for sustainable community living, addressing waste management and water pollution.

Parasitology and Infectious Diseases:

  • Extensive work in parasitology, including studies on gastrointestinal parasites in children and parasitic nematodes in insects, contributes to understanding and managing parasitic infections in communities.

šŸ“ššŸŒPublication Top Notes

  1. Synergistic anticancer effects of omega-3 Fatty acids (EPA/DHA) and anticancer drug Doxorubicin against human lung adenocarcinoma. Food Bioscience, 2024.

2. Epidermal Mucus Extracts of three Freshwater Air Breathing Fish Species against Gram Positive and Gram Negative Human Pathogenic Bacteria. Indian Journal of Fisheries, 2019.

3. Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: A review on in-vitro studies. Archives of Polish Fisheries, 2019.

4. Deficiency of protein, fat and vitamins in freshwater catfish, Clarias batrachus: morphological symptoms and impact on growth performance. Borneo Journal of Marine Science and Aquaculture, 2019.

5. Anticancer potency of skin mucus extract derived from Channa punctatus, Channa striatus, and Heteropneustes fossilis: An in-vitro analysis. Molecular and Cellular Biochemistry (under review).